Objective Determine the prevalence of sialadenitis in a group of patients treated with
radioactive iodine (RAI) for well-differentiated thyroid cancer and assess whether RAI …

Background: An important side effect of radioactive iodine (RAI) therapy in patients treated
for papillary thyroid cancer (PTC) is chronic sialadenitis. Neck ultrasonography (US) easily …

Purpose This study aims to elaborate on the current knowledge concerning the mechanism,
frequency, clinical manifestations, diagnostic procedures, prevention, and management of …

Background Radioactive iodine (131I) is one of the treatments of hyperthyroidism and
differentiated thyroid carcinoma (DTC). Swelling of salivary glands are one of the possible …

Purpose Despite having a generally favorable prognosis, differentiated thyroid cancer is
known to have a significant, long-term impact on the quality of life of survivors. We wished to …

Background. The purpose of this study was to assess the late side effects of radioiodine
therapy (RIT) on salivary gland function. One hundred eighty two patients were evaluated …

Introduction Salivary gland dysfunction (eg, sialadenitis and xerostomia) is the most
common complication of radioactive iodine (RAI) therapy for differentiated thyroid cancer …

Sialadenitis is one of the common complications of radioiodine treatment for thyroid
malignancy. The aim of this study was to evaluate the prevalence of radioiodine-induced …

Oral Diseases (2011) 17, 154–161 Radioiodine (131I) is an important therapy for patients
who have well‐differentiated thyroid cancer. However, 131I may also result in side effects in …

Background Although many studies focus on short‐term side effects of radioiodine therapy,
almost none studied long‐term side effects. We assessed radioiodine long‐term salivary …